As of 2025-11-03, the Relative Valuation of Cardiff Oncology Inc (CRDF) is (11.85) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.35 USD, the upside of Cardiff Oncology Inc based on Relative Valuation is -604.2%.
The range of the Relative Valuation is (9.51) - (13.24) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 17.3x | 15.5x |
| Forward P/E multiples | 11.7x - 18.8x | 15.4x |
| Fair Price | (9.51) - (13.24) | (11.85) |
| Upside | -504.6% - -663.2% | -604.2% |
| Date | P/E |
| 2025-10-30 | -2.91 |
| 2025-10-29 | -2.92 |
| 2025-10-28 | -3.00 |
| 2025-10-27 | -2.99 |
| 2025-10-24 | -2.91 |
| 2025-10-23 | -2.88 |
| 2025-10-22 | -2.82 |
| 2025-10-21 | -2.91 |
| 2025-10-20 | -2.97 |
| 2025-10-17 | -2.86 |
| 2025-10-16 | -2.92 |
| 2025-10-15 | -3.14 |
| 2025-10-14 | -2.96 |
| 2025-10-13 | -2.95 |
| 2025-10-10 | -2.88 |
| 2025-10-09 | -3.10 |
| 2025-10-08 | -3.10 |
| 2025-10-07 | -2.92 |
| 2025-10-06 | -2.87 |
| 2025-10-03 | -2.86 |
| 2025-10-02 | -2.74 |
| 2025-10-01 | -2.71 |
| 2025-09-30 | -2.69 |
| 2025-09-29 | -2.71 |
| 2025-09-26 | -2.69 |
| 2025-09-25 | -2.66 |
| 2025-09-24 | -2.70 |
| 2025-09-23 | -2.66 |
| 2025-09-22 | -2.70 |
| 2025-09-19 | -2.67 |
| 2025-09-18 | -2.82 |
| 2025-09-17 | -2.62 |
| 2025-09-16 | -2.61 |
| 2025-09-15 | -2.66 |
| 2025-09-12 | -2.67 |
| 2025-09-11 | -2.71 |
| 2025-09-10 | -2.66 |
| 2025-09-09 | -2.78 |
| 2025-09-08 | -2.91 |
| 2025-09-05 | -2.83 |
| 2025-09-04 | -2.78 |
| 2025-09-03 | -2.56 |
| 2025-09-02 | -2.54 |
| 2025-08-29 | -2.74 |
| 2025-08-28 | -2.71 |
| 2025-08-27 | -2.83 |
| 2025-08-26 | -2.88 |
| 2025-08-25 | -2.88 |
| 2025-08-22 | -3.03 |
| 2025-08-21 | -2.95 |